Literature DB >> 23233623

Low blood counts: immune mediated, idiopathic, or myelodysplasia.

Peter Valent1.   

Abstract

Traditionally, cytopenias are classified as deficiency mediated, immune mediated, BM failure induced, renal, or idiopathic, with the latter including the so-called idiopathic cytopenias of undetermined significance (ICUS). Clinical findings, symptoms, blood counts, BM findings, and other laboratory parameters are usually sufficient to reveal the type and cause of a marked cytopenia. However, in patients with chronic mild cytopenia, it may be a challenge for the physician to establish a correct diagnosis. In such patients, laboratory features and findings often reflect a diagnostic interface, so that criteria that are otherwise robust may hardly be applicable or are not helpful. Even if the BM is examined, the diagnosis often remains uncertain in these patients. In addition, more than one potential cause of cytopenia may be present, especially in the elderly. A myelodysplastic syndrome (MDS) or another BM disorder, but also an overt autoimmune or other inflammatory disease, may develop during follow-up in these patients. A key problem is that in an early phase of MDS, most laboratory and clinical signs are "nonspecific." One of the very few reliable peripheral blood parameters distinguishing between an early or "pre-phase" of MDS and most other causes of a mild cytopenia are the numbers of circulating colony-forming progenitor cells. In addition, flow cytometric and molecular investigations may sometimes assist in the delineation between clonal and reactive conditions underlying mild cytopenias. This review provides an overview of diagnostic approaches and algorithms for patients with mild unexplained cytopenia(s).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233623     DOI: 10.1182/asheducation-2012.1.485

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  19 in total

1.  High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology.

Authors:  Ozlen Bektas; Aysegul Uner; Seda Muruvvet Aydin; Eylem Eliacik; Burak Uz; Ayse Işık; Ibrahim Celalettin Haznedaroğlu; Hakan Goker; Nilgun Sayinalp; Salih Aksu; Halûk Demiroglu; Osman Ilhami Ozcebe; Yahya Buyukasik
Journal:  Int J Hematol       Date:  2015-05-26       Impact factor: 2.490

2.  Anaemia with inflammation responding to lenalidomide.

Authors:  Faysal Haroun; Andrew Mener; Jacob Elkon; Imad Tabbara
Journal:  BMJ Case Rep       Date:  2016-10-13

Review 3.  The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

Review 4.  The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.

Authors:  Amy E DeZern; Mikkael A Sekeres
Journal:  Oncologist       Date:  2014-06-04

5.  Burst-forming unit-erythroid assays to distinguish cellular bone marrow failure disorders.

Authors:  Amy E DeZern; Jeffrey Pu; Michael A McDevitt; Richard J Jones; Robert A Brodsky
Journal:  Exp Hematol       Date:  2013-05-06       Impact factor: 3.084

Review 6.  ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications.

Authors:  Peter Valent
Journal:  Pathobiology       Date:  2018-06-01       Impact factor: 4.342

Review 7.  Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?

Authors:  Rafael Bejar
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

8.  Can neutrophil/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism?

Authors:  Murat Dağdeviren; Tolga Akkan; Dilek Yapar; Serdar Karakaya; Tanyel Dağdeviren; Derun Ertuğrul; Mustafa Altay
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

Review 9.  Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood.

Authors:  Miriam Erlacher; Brigitte Strahm
Journal:  Front Pediatr       Date:  2015-07-13       Impact factor: 3.418

Review 10.  A rare case of angiosarcoma with skull masses and erythropenia and thrombocytopenia: A case report and review of literature.

Authors:  Liansheng Gao; Weilin Xu; Tao Li; Huali Luo; Shiying Gai; Ruxin Xing; Gao Chen; Yili Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.